# Continuous Renal Replacement

Form of extracorporeal blood purification using a continuous circuit, providing:

* Continuous control of:
	* Fluid status
	* Acid-base status
	* Electrolyte balance
	* Intracerebral water
* Good haemodynamic stability
* Minimal infective risk
* Facilitation of **renal recovery**

## Principles

{{< include /includes/rrt_principles.qmd >}}


### Types of CRRT

There are a number of technical variations of CRRT based on the physical principles used:

* **Haemofiltration**\
No dialysate is used.
	* Ultrafiltration results in a solute-water mix filtered across the semi-permeable membrane\
	* A substitution solution is used to replace lost volume\
	The difference between the ultrafiltration volume produced and the substitution solution infused is the fluid removal.
* **Haemodialysis**\
Counter-current delivery of dialysis solution.
	* Clearance is almost entirely by diffusion
* **Haemodiafiltration**\
Combination of:
	* Counter-current dialysis solution\
	Solute clearance by diffusion.
	* Ultrafiltration\
	Additional substitution solution used to replace lost volume.

## Indications

Indications for CRRT include:

:::column-margin
CRRT may be initiated in ICU based on anticipation of reaching these thresholds, or on a series of composite features that individually do not meet the threshold.
:::

* Established renal failure
* Volume overload\
With oliguria/anuria.
* Solute
	* Urea >35mmol/L
	* Uraemic complications
	* Hyperkalaemia
	* Hyponatraemia <110mmol/L
	* Hypernatraemia >160mmol/L
* Other
	* Dialysable toxin
	* Hyperthermia >40°C


## Contraindications

## Equipment

Vascular dialysis catheter:

* Uncuffed, non-tunnelled catheter
* Preferentially sited in:
	* Right IJV
	* Femoral vin
	* Left IJV
	* Dominant SCV  
	Risk of central vein stenosis with SCV insertion.
	* Non-dominant SCV
* Positioned at the junction of the SCV and RA
	* Risk of atrial erosion if in too far
	* Risk of central vein stenosis if abutting SVC 

## Technique

Clinician-adjustable values in CRRT include:

* Dose\
Effluent production in ml/kg/hr.
	* 25-30ml/kg/hr 



## Anticoagulation

Anticoagulation is frequently used to prevent clotting of the filter and circuit, but must be balanced against risks of bleeding. In general:

* Circuit anticoagulation is recommended when patient is:
	* Not coagulopathic
	* Not systemically anticoagulated
* Citrate is preferred if there is no contraindication
* UFH is used if citrate is contraindicated
* If there is an ↑ bleeding risk:
	* Use regional citrate/calcium in CRRT
	* Avoid regional UFH/LMWH  
	If citrate is contraindicated, then no anticoagulation should be used.
* For patients with contraindications to citrate and UFH, and without coagulopathy:
	* Anticoagulation is still recommended
	* Direct thrombin inhibitors (argatroban)  
	Contraindicated in hepatic failure.
	* Factor Xa inhibitors  
	Danaparoid, fondaparinux.


:::column-margin
Acceptable filter life is ~24 hours.
:::

+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+
| Technique                                       | Method                                                                                      | Advantages                                                                                  | Disadvantages                                                              |
+=================================================+=============================================================================================+=============================================================================================+============================================================================+
| No anticoagulant                                |                                                                                             | - Used in patients with endogenous coagulopathy or other contraindication                   |                                                                            |
+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+
| Heparin alone                                   | Heparin <500 units/hr                                                                       | - Easy, cheap, familiar, available                                                          | - HITTS                                                                    |
|                                                 |                                                                                             | - Minimal effect on systemic coagulation                                                    | - Heparin resistance                                                       |
|                                                 |                                                                                             | - Therapeutic heparinisation can be used if systemic anticoagulation is indicated (e.g. PE) |                                                                            |
+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+
| Regional anticoagulation with citrate           | Citrate given into the access line and reversed with calcium given into the return line.    | - Regional anticoagulation reduces systemic haemorrhage                                     | - Special dialysate required                                               |
|                                                 |                                                                                             | - Longer filter life                                                                        | - Citrate toxicity (especially hepatic failure, shock)\                    |
|                                                 |                                                                                             | - ↓ Transfusion and major bleeding compared to UFH                                          | Metabolic acidosis, hypocalcaemia, widening total calcium:ionised calcium. |
+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+
| Regional anticoagulation with heparin/protamine | Heparin into access line and reversed with protamine at a fixed ratio into the return line. | - Easy, cheap, familiar, available                                                          | - HITTS                                                                    |
|                                                 |                                                                                             | - Reversible                                                                                | - Heparin resistance                                                       |
|                                                 |                                                                                             | - Can be monitored                                                                          | - Narrow TI                                                                |
|                                                 |                                                                                             | - Short half-life                                                                           | - Unpredictable kinetics                                                   |
+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+
| Systemic low-molecular weight heparin           |                                                                                             | - Predictable kinetics                                                                      | - May accumulate in renal failure                                          |
|                                                 |                                                                                             | - Does not require monitoring                                                               | - Requires anti-Xa for monitoring                                          |
|                                                 |                                                                                             | - Less HITTS                                                                                | - Incompletely reversed with protamine                                     |
|                                                 |                                                                                             |                                                                                             | - More expensive                                                           |
+-------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+

: Comparison of Anticoagulation Techniques

### Responding to Filter Clotting

* Evaluate for mechanical causes\
Cannula:
	* Position
	* Flow rates
	* Kinking


## Complications

* Vascular access
* Haemodynamic instability\
More pronounced with more aggressive dialysis modes (particularly IHD).


---

## References

1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. [KDIGO Clinical Practice Guideline for Acute Kidney Injury](http://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf). Kidney inter., Suppl. 2012; 2: 1–138.
2. Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.
